Suraj Saksena

Suraj Saksena's work experience includes:

- Senior Director, Development & Scientific Operations at Freenome since July 2022.

- Senior Director, Reagents & NGS-based IVD Systems at Adaptive Biotechnologies Corp. from May 2021 to July 2022.

- Science & Technology Leader, Custom Reagents at BD from 2019 to May 2021.

- Associate Director, Clinical Reagents at BD from May 2016 to May 2019.

- Director, Assay Systems at Theranos Inc. from January 2015 to May 2016.

- Manager at Theranos Inc. from March 2014 to December 2014.

- Team Lead at Theranos Inc. from May 2012 to March 2014.

- Senior Scientist at Theranos Inc. from October 2011 to May 2012.

- Senior Research Investigator at Amicus Therapeutics from July 2010 to July 2011.

- Research Investigator at Amicus Therapeutics from December 2008 to June 2010.

- American Heart Association Postdoctoral Fellow at Weill Institute for Cell & Molecular Biology, Cornell University from April 2007 to November 2008.

- Howard Hughes Medical Institute Postdoctoral Fellow at Howard Hughes Medical Institute UCSD School of Medicine from January 2006 to March 2007.

During their career, Suraj Saksena has conducted research in various fields and obtained funding for their projects. Suraj has demonstrated expertise in developing therapeutics and investigating biological pathways. Suraj has also published numerous peer-reviewed publications in top-rated scientific journals.

Suraj Saksena completed their Executive MBA from the Quantic School of Business and Technology in 2023. Prior to that, they earned their PhD in Biochemistry & Biophysics from Texas A&M University from 2000 to 2005. Suraj also obtained a MS degree in Biochemistry from the University of Delhi South Campus from 1998 to 2000 and a BS degree in Biochemistry from the University of Delhi from 1995 to 1998. In addition, Suraj has obtained certifications in Managerial Accounting, Accounting I- Fundamentals, Accounting II- Revenues & Expenses, Accounting III- Financial Statements, Cultural Intelligence, and Stocks & Bonds from the Quantic School of Business and Technology. Suraj is also a Board Certified Clinical Chemist, certified by the National Registry of Certified Chemists in 2015.